Results 231 to 240 of about 581,958 (255)

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Lancet Oncology, The, 2021
Jonathan A Ledermann, Rebecca Asher, Jacob Korach   +2 more
exaly  

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

Journal of Clinical Oncology, 2023
Paul DiSilvestro, Susana Banerjee, Nicoletta Colombo   +2 more
exaly  

ESTIMATIVA DE PERDA DE SOLO POR EROSÃO HÍDRICA EM BACIA HIDROGRÁFICA

2023
Mariane Rodrigues da Vitoria, Klaus de Oliveira Abdala   +1 more
openaire   +1 more source

Solo female travel risks, anxiety and travel intentions: examining the moderating role of online psychological-social support

Current Issues in Tourism, 2021
Deniz Karagöz, Cem Işık, Tarik Dogru
exaly  

Ride solo or pool: Designing price-service menus for a ride-sharing platform

European Journal of Operational Research, 2021
Ricky Roet-Green
exaly  

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial

Journal of Clinical Oncology, 2020
David Cibula, Nicoletta Colombo, Jae-Weon Kim   +2 more
exaly  

PERDA DE SOLO POR ESCOAMENTO SUPERFICIAL EM ARGISSOLO DO NOROESTE PARANAENSE

Anais do(a) Anais da VIII Reunião Paranaense de Ciência do Solo: Conservação de Solo e da água no Paraná - avanços, retrocessos e (re)usos, 2023
GEOVANE FIGUEIREDO FERREIRA, Amanda Eustachio Pereira, Osvaldo Leite da Silva Junior, THAISE MOSER TEXEIRA, EDISON SCHMIDT FILHO   +4 more
openaire   +1 more source

Public transport versus solo travel mode choices during the COVID-19 pandemic: Self-reported evidence from a developing country

Transportation Engineering, 2021
Muhammad Abdullah, Nazam Ali, Muhammad Ashraf Javid   +2 more
exaly  

Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)

British Journal of Dermatology, 2020
Andreas Wollenberg, Andrew Blauvelt, El Simpson   +2 more
exaly  

Power and empowerment: How Asian solo female travellers perceive and negotiate risks

Tourism Management, 2018
Elaine Chiao Ling Yang
exaly